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Introduction {#sec1}
============

Plasma cells (PCs) can persist for long time periods in the bone marrow (BM). However, PCs are not intrinsically long lived ([@bib27]; [@bib41]) and die quickly when isolated and cultured *in vitro*, suggesting that their persistence in the BM depends on survival factors provided in the BM ([@bib6]). In the BM, PCs are located individually in direct contact to mesenchymal stromal cells, and it has been postulated that these stromal cells organize a survival niche for the PCs ([@bib28]; [@bib39]; [@bib48]; [@bib51]). How the survival is mediated at a molecular level has remained unclear. Essential for PC survival is signaling through the B cell maturation antigen (BCMA; CD269) receptor of the PCs ([@bib34]) induced by its two ligands, namely, a proliferation-inducing ligand (APRIL; CD256) or B-cell-activating factor (BAFF; BLys and CD257) ([@bib5]) and the antiapoptotic protein myeloid cell leukemia 1 (MCL-1) ([@bib37]). Evidence suggests that stromal cells might contribute directly to PC survival in the BM. Antibodies against the adhesion molecules integrin αLβ2 (lymphocyte-function-associated antigen \[LFA-1\]; CD11a/CD18) and integrin α4β1 (very late antigen \[VLA-4\]; CD49d/CD29), expressed by the PCs, ablate PCs from the BM ([@bib11]). Ligands for both of these integrins, vascular cell adhesion molecule 1 (VCAM; CD106) and intercellular adhesion molecule 1 (ICAM; CD54), are expressed by BM stromal cells, suggesting that integrin-mediated binding of PCs to stromal cells might directly, by the focal adhesion kinase/phosphatidylinositol 3-kinase (PI3K) pathway ([@bib13]; [@bib35]) promote PC persistence in the BM. In line with this idea, CD37-deficient antibody-secreting cells, which show impaired clustering of VLA-4, have diminished PI3K signaling and impaired survival ([@bib49]). Whether or not BCMA signaling and contact to stromal cells are sufficient to maintain the survival of memory PCs and how they prevent death of the PC have not been elucidated.

Here, we demonstrate, both *in vivo* and *ex vivo*, that BM PC survival is dependent on PI3K signaling. PI3K signaling is induced in PCs by direct contact to stromal cells and leads to inactivation of Forkhead-Box-Protein O1/3 (FoxO1/3), which is essential for the survival of the PCs. PC survival also depends on nuclear factor "kappa-light-chain-enhancer" of activated B cell (nuclear factor κB \[NF-κB\]) signaling, which is induced by APRIL. Pan-caspase inhibition can substitute for both signaling pathways and rescues PC survival *in vitro*. Interestingly, stromal cell contact alone but not APRIL prevents activation of the mitochondrial-stress-associated caspases 3 (Casp3) and 7, whereas APRIL prevents activation of the endoplasmic reticulum (ER)-associated Casp12.

Results {#sec2}
=======

Contact to Stromal Cells and APRIL-Induced Signaling Pathways Prevent Caspase-Mediated Cell Death of PCs {#sec2.1}
--------------------------------------------------------------------------------------------------------

Memory PCs were isolated from the BM of chicken gamma globulin (CGG)-immunized C57BL/6J mice more than 30 days after the last immunization by magnetic depletion of CD49b^+^ and B220^+^ cells, followed by magnetic enrichment of CD138^+^ cells. Using this protocol, we achieved purities of more than 90% and recovery rates of about 35% of viable BM PCs. Isolated PCs expressed the PC transcription factor BLIMP-1 and were Ki-67 negative, the latter indicating that the cells were resting in terms of proliferation ([Figure S1](#mmc1){ref-type="supplementary-material"}A and S1B). The cells were cultured *in vitro* with or without murine stromal cell line ST2 at an initial ratio of 1:1 in the presence or absence of APRIL. On days 1, 3, and 6 of the culture, viable PCs (CD138^++^/4′,6-diamidine-2-phenylindole dihydrochloride negative \[DAPI^−^\]) were enumerated and analyzed by flow cytometry. All cultures were performed under physiological oxygen levels of 4.2% O~2~ to mimic the BM environment ([@bib32]; [@bib43]). PCs rapidly died within days when isolated from the BM and cultured in medium (median viability: day 1: 43.27%, day 3: 7.095%, day 6: 0%). However, PC survival was significantly improved when the cells were co-cultured with ST2 cells and in the presence of the cytokine APRIL (median viability: day 1, 83.14%; day 3, 72.19%; day 6, 51.20%). Co-culture of PCs with ST2 cells alone (median viability: day 1, 67.47%; day 3, 25.42%; day 6, 19.07%) or with APRIL alone (median viability: day 1, 55.24%; day 3, 43.15%; day 6, 23.27%) were not sufficient to maintain PCs alive ([Figure 1](#fig1){ref-type="fig"}A). The expression of CD138 and BLIMP-1 on the PCs was not altered during the 6 days of *in vitro* culture with ST2 cells and APRIL, and antibody secretion was maintained ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D). To confirm that the identity of PCs was maintained for 3 days in co-culture with ST2 cells and APRIL, we compared their global transcriptomes to those of *ex*-*vivo*-isolated PCs ([Figures S1](#mmc1){ref-type="supplementary-material"}E and S1F). Of 10,000 genes expressed at statistically significant levels, only 41 genes showed a significant difference (p \< 0.01) in expression before and after culture ([Figure S1](#mmc1){ref-type="supplementary-material"}H). The transcription factor AP-1 (JunB, Jun, Fos) was highly expressed in PCs isolated from BM but was not or only marginally expressed in PCs cultivated for 3 days. Expression of AP-1 and other stress-inducible genes (12; group A) may reflect stress induced by the tedious isolation procedure of PCs from the BM, as compared to their isolation from cell culture. A number of hypoxia-related and metabolic genes (15 genes; group B) were upregulated in cultivated PCs, compared with PCs directly isolated from the BM. This finding may reflect the extended time the PCs spent under normoxic conditions during the isolation period. Finally, other genes (12 genes, group C), most prominently CXCL12, not expressed in PCs isolated directly from the BM, but in those isolated from cell culture on day 3, may indicate contaminating stromal cells that were abundant in cell culture due to the ST2 cell line. Expression of the genes *CD138*, *Foxo1* and *3*, *Prdm1*, *Irf4*, *Noxa*, *Bcl2l11*, *Bcl2*, and *Mcl1* was not significantly different ([Figure S1](#mmc1){ref-type="supplementary-material"}G).Figure 1Survival of Bone Marrow Memory PCs Is Dependent on Direct Cell Contact with Stromal Cells and the Presence of APRIL(A) Survival of primary murine bone marrow PCs cultured ± ST2 cells and ± APRIL for up to 6 days at 4.2% O~2~. Viable plasma cells (CD138^++^/DAPI^−^) were counted by flow cytometry. Median of at least 5 pooled independent experiments with at least n = 14 technical replicates for each group. Statistics: Kruskal-Wallis test.(B) Isolated PCs treated with or without pan-caspase inhibitor when cultured ± ST2 cells and ± APRIL. Viable PCs were counted on day 1 of culture (pooled from two independent experiments with a minimum of n = 7 technical replicates for each group). Statistics: ordinary one-way ANOVA.(C) Survival of PCs in the presence of APRIL on day 1 and day 3, when cultured in transwell or directly contacting ST2 cells (pooled from two independent experiments with n = 4 technical replicates for each group). Statistics: t test.(D) Survival of PCs on day 1 and day 3 treated with specific siRNA directed against ITGB1 and scrambled controls (pooled from three independent experiments with n = 9 technical replicates for each group). Statistics: ordinary one-way ANOVA.

The survival of *ex*-*vivo*-isolated BM PCs cultured with APRIL or ST2 cells alone was rescued by pan-caspase inhibitors ([Figure 1](#fig1){ref-type="fig"}B), suggesting that co-culture of PCs with ST2 cells and APRIL prevents caspase-mediated cell death.

Interaction between stromal cells and PCs has been suggested to be mediated by direct cell contact ([@bib28]; [@bib39]; [@bib48]; [@bib51]) by VCAM1/VLA4 and ICAM/LFA1 interaction ([@bib11]). When culturing PCs and ST2 cells in a transwell assay, survival of PCs was significantly decreased (median viability for ST2 cells: day 1, 66%; day 3, 51%; and for PCs: day 1, 30%; day 3, 22%) compared with co-culturing conditions ([Figure 1](#fig1){ref-type="fig"}C). Small interfering RNA (siRNA)-mediated knockdown of integrin β1 (CD29/ITGB1), a subunit of the VLA4 (Integrin a4β1) heterodimer by 50% ([Figure S4](#mmc1){ref-type="supplementary-material"}A), significantly reduced the survival of PCs in co-culture with ST2 cells and APRIL *ex vivo* ([Figure 1](#fig1){ref-type="fig"}D), indicating that direct cell contact is required for survival and that contact-mediated survival is in part mediated by integrin β1 (median viability for scrambeld (scr): day 1, 100%; day 3, 109%; and for ITGB1: day 1, 100%; day 3, 87%).

Inhibition of PI3K Signaling Results in PC Death *Ex Vivo* {#sec2.2}
----------------------------------------------------------

Preincubation of *ex-vivo*-isolated BM PCs with the irreversible PI3K inhibitor Wortmannin resulted in a dose-dependent decrease in survival of the PCs, when co-cultured with ST2 cells in the presence of APRIL (viability for ST2+A: day 1, 101%; day 3, 76%; +Wortmannin 0.6 μM: day 1, 100%; day 3, 66%; +Wortmannin 3 μM: day 1, 102%; day 3, 66%; +Wortmannin 15 μM: day 1, 73%; day 3, 37%; +Wortmannin 77 μM: day 1, 68%; day 3, 20%) ([Figure 2](#fig2){ref-type="fig"}A). Using an alternative pan-PI3K inhibitor, LY294002, PC survival was also decreased in a dose-dependent manner (viability of ST2+A +LY29400 10 μM: day 1, 62%; day 3, 68%; +LY29400 20 μM: day 1, 44%; day 3, 37%; +LY29400 40 μM, day 1, 24%; day 3, 5.7%) ([Figure 2](#fig2){ref-type="fig"}B). More specific inhibition of any of the four known PI3K subunits α, β, γ, or δ did not impact the survival of PC ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Only when any three subunits were simultaneously inhibited, PC survival was reduced to a similar degree as it was observed in the presence of Wortmannin ([Figure 2](#fig2){ref-type="fig"}C). Apparently, PCs have no particular requirement regarding the subunit composition of their PI3K. Inhibition of the NF-κB pathway downstream of BCMA, the receptor for APRIL, with the pan-NF-κB inhibitor IKK16 ([@bib47]; [@bib50]) also resulted in a dose-dependent death of the PCs ([Figure S2](#mmc1){ref-type="supplementary-material"}B), demonstrating that both signaling pathways downstream of stromal cell contacts and BCMA are nonredundant and essential for PC survival.Figure 2Stromal-Cell-Contact-Induced PI3K Signaling Is Essential for Survival of Memory Bone Marrow PCs *Ex Vivo* and *In Vivo*(A--C) Survival of PCs preincubated with different concentrations of the irreversible PI3K-inhibitor Wortmannin (A), directly treated during culture with the inhibitor LY294002 (B), or with combinations of three subunit-specific PI3K inhibitors determined by counting viable CD138^++^/DAPI^−^ PCs by flow cytometry (C) (pooled from two independent experiments with n = 6 technical replicates for each group). Statistics: ordinary one-way ANOVA.(D) Experimental design: C57BL/6J were primed and boosted twice (days 21 and 42) with CGG-NP/IFA and treated with the PI3K-inhibitor Wortmannin on days 90, 92, and 94. On day 95, the mice were analyzed.(E) Representative plot of B220^−^/CD138^++^/CD19^−^ PCs in the bone marrow from control and Wortmannin-treated mice gated on DAPI^−^ viable cells.(F) Absolute cell counts of total bone marrow cells and memory PCs, in the bone marrow in control and Wortmannin-treated mice. Median of two pooled independent experiments with n = 5 biological replicates. Statistics: t test.

Inhibition of PI3K Signaling Ablates Resident Memory PCs of the BM {#sec2.3}
------------------------------------------------------------------

To verify the relevance of PI3K signaling for the persistence of PC *in vivo*, we treated mice with an established immune memory with 1.2 mg/kg of Wortmannin ([@bib33]), 7 weeks following the last immunization, and enumerated memory PCs in the BM on day 95 ([Figures 2](#fig2){ref-type="fig"}D and 2E). Counts of total BM cells did not differ between mice treated with Wortmannin and control mice (2.46 × 10^8^ versus 2.37 × 10^8^, respectively) ([Figure 2](#fig2){ref-type="fig"}F). However, PCs were significantly reduced by about 33% (5.1 × 10^5^ versus 3.4 × 10^5^).These results show that the persistence of memory PCs in the BM, like in the *ex vivo* niche provided by ST2 cells and APRIL, is conditional on continued PI3K signaling.

Stromal Cell Contact Downregulates the FoxO1/3 Pathway {#sec2.4}
------------------------------------------------------

PI3K activation leads to the downregulation of FoxO1 and FoxO3 ([@bib15]; [@bib20]; [@bib38]). BM PCs, when co-cultured with ST2 cells, significantly downregulated the expression of FoxO1 and FoxO3 independently of APRIL, already on day 1 of co-culture (FoxO1 geometric mean expression: APRIL: 1,820 ± 62, ST2: 1,374 ± 76, ST2+A: 1,348 ± 35; FoxO3 geometric mean expression: APRIL: 2,446 ± 282, ST2: 1,777 ± 134, ST2+A: 1,960 ± 106) ([Figures 3](#fig3){ref-type="fig"}A and 3B). Adding APRIL alone or in combination with ST2 cells did not affect the expression of FoxO1/3 proteins. To determine whether downregulation of FoxO1/3 expression is the critical event downstream of PI3K activation, FoxO1/3 expression was knocked down by using specific siRNA by 23% and 21%, respectively ([Figures S2](#mmc1){ref-type="supplementary-material"}B and S2C). Knockdown of FoxO1/3 in PCs could completely restore PC survival in the absence of ST2 cells when PCs were cultured with APRIL alone (mean viability: day 1, APRIL+ scr: 99% ± 13%, APRIL+ FoxO: 102% ± 14%, ST2+A+scr: 101% ± 33%; day 3, APRIL+ scr: 52% ± 26%, APRIL+ FoxO: 79% ± 18%, ST2+A+scr: 89% ± 24%) ([Figure 3](#fig3){ref-type="fig"}C). These results demonstrate that stromal cell contact is supporting the survival of PCs by downregulation of FoxO1/3.Figure 3Stromal-Cell-Contact-Induced PI3K Signaling Downregulates FoxO1/3 Protein Expression and Is Essential for Survival of Memory Bone Marrow PCs(A and B) FoxO1 (A) and FoxO3 (B) expression of CD138^+^ PCs, as determined by flow cytometry (geometric mean fluorescence intensity, pooled from two independent experiments with n = 8 technical replicates for each group). Statistics: ordinary one-way ANOVA.(C) Survival of PCs treated with siRNA specific for FoxO1/FoxO3 or scrambled control on day 1 and 3 of culture with APRIL alone or ST2 and APRIL counted by flow cytometry. Median of at least three pooled independent experiments with n = 3 technical replicates for each group. Statistics: ordinary one-way ANOVA.

Stromal Cell Contact and APRIL Signaling Pathways Address Distinct Caspases {#sec2.5}
---------------------------------------------------------------------------

As the survival of *ex*-*vivo*-isolated BM PCs cultured with APRIL or ST2 cells alone was rescued by pan-caspase inhibitors ([Figure 1](#fig1){ref-type="fig"}B), we aimed at determining which caspases are affected by stromal cell contact and APRIL, respectively. Activation of the caspases was measured on the single-cell level by using antibodies or fluorescent caspase-specific peptides and controlled using a pan-caspase inhibitor and Wortmannin, blocking PI3K signaling, or tunicamycin, inducing the unfolded protein response (UPR), respectively ([Figure S3](#mmc1){ref-type="supplementary-material"}). Co-culture of PCs with ST2 cells led to significantly reduced levels of cleavage and activation of the effector Casp3 and 7 ([Figures 4](#fig4){ref-type="fig"}A and 4B) compared to levels of culture with APRIL alone. The addition of APRIL to the co-culture with ST2 cells did not further impact the activation of Casp3 or 7. However, APRIL, together with ST2 cells, led to a significant reduction of the activation of the ER-associated Casp12 ([Figure 4](#fig4){ref-type="fig"}C).Figure 4Contact with Stromal Cells Inhibits Activation of Caspase 3 and 7, whereas APRIL Inhibits Activation of Caspase 12Expression of activated caspase 3 (A), caspase 7 (B), and caspase 12 (C) of CD138^+^ PCs determined by flow cytometry, shown as geometric mean fluorescence intensity, on day 1 in PCs cultured under the indicated conditions (pooled from a minimum of two independent experiments with n = 6--12 technical replicates for each group). Statistics: Kruskal-Wallis test (activated Casp3), ordinary one-way ANOVA (activated Casp7/Casp12).

Stromal Cell Contact and APRIL Synergize to Induce the Expression of IRF4 {#sec2.6}
-------------------------------------------------------------------------

ST2 cells and APRIL also synergized to upregulate the expression of IRF4 on the single-cell level ([Figure S2](#mmc1){ref-type="supplementary-material"}C). IRF4 has been demonstrated previously to be indispensable for the survival of PCs *in vivo* ([@bib46]). Inhibition of either signaling pathways downstream of stromal cell contact or APRIL, i.e., PI3K using Wortmannin or NF-κB using IKK16, resulted in a decrease in IRF4 expression ([Figure S2](#mmc1){ref-type="supplementary-material"}D).

Discussion {#sec3}
==========

Long-lived memory PCs persist for a lifetime in mice ([@bib29]; [@bib42]), in nonhuman primates ([@bib17]), and in humans ([@bib26]). They form an independent population of memory cells ([@bib7]; [@bib39]). Memory PCs are evenly distributed throughout the BM and most if not all of them directly contact a mesenchymal stromal cell ([@bib51]). It is suggestive that these stromal cells organize a survival niche, which supports longevity of the PCs ([@bib28]). It is still enigmatic, however, how stromal cells organize the PC survival niche. It has been postulated that they attract cells secreting the cytokines APRIL and/or BAFF, both ligands for the receptor BCMA (CD269), signaling by the NF-κB pathway ([@bib8]; [@bib18]; [@bib34]). Blocking both cytokines ablates PCs from the BM ([@bib4]; [@bib5]). The stromal cell may also contribute directly to the survival of PCs by integrin-mediated cell contact signaling ([@bib11]) inducing PI3K signaling ([@bib49]). Here, we show that indeed both signaling pathways are essential and complementary for PC survival and that cell-contact-induced PI3K signaling acts through downregulation of FoxO1/3 and blocks activation of caspases 3 and 7, but not 12. In complementation, APRIL signaling blocks activation of Casp12, but not 3 and 7. Direct contact between the stromal cell and the PCs and APRIL signaling thus in synergy prevent apoptosis of the PCs induced by ER and mitochondrial stress. It has been shown previously that primary human-antibody-secreting cells isolated from peripheral blood 7 days after booster vaccination can be maintained *in vitro* by soluble factors secreted by BM-derived stromal cells ([@bib32]), independently of direct cell-cell contact. It is unclear whether this apparent discrepancy to the results shown here points to a difference in survival requirements of antibody-secreting cells circulating in the blood, within days after antigenic stimulation, i.e., recently generated plasmablasts and long-lived PCs residing in the BM.

An analysis of the lifestyle of memory PCs has been hampered by their low frequency in the BM, as well as by the fact that they die rapidly when isolated and cultured *ex vivo* ([@bib6]), as is confirmed here. Cytokines prolonging their survival *ex vivo* have been reported ([@bib6]; [@bib9]; [@bib23]; [@bib30]). Here, we describe a culture system providing stroma cell contact and a ligand for BCMA and show that those two signals are necessary and sufficient to maintain survival of resident PCs of the BM. When cultured on ST2 cells, in the presence of the cytokine APRIL, 50 to 80% of *ex*-*vivo*-isolated BM PCs survived for more than 5 days. The PCs maintained their transcriptional identity, with less than 41 transcripts differentially expressed between PCs directly isolated from the BM and those cultured for 3 days.

*In vivo*, it remains unclear which cells provide the cytokines APRIL and/or BAFF to the PCs. Eosinophilic granulocytes have been proposed ([@bib8]), but their role has been questioned ([@bib14]). We have shown recently that a subpopulation of BM stromal cells does produce BAFF ([@bib1]). PCs are known to have two receptors for the cytokines APRIL and BAFF, namely TACI and BCMA ([@bib34]; [@bib37]). Among them, BCMA signaling has been suggested to be vital for PC survival in the BM ([@bib5]; [@bib34]). It is known that the BCMA receptor, when activated by APRIL, signals by the TRAF/NF-κB/p38 pathway ([@bib18]). Similarly, inhibition of the NF-κB pathway blocks survival of PCs in the *ex vivo* niche described here. In the presence of stromal cells, APRIL significantly inhibits the activation of Casp12, but not of Casp3 and 7. Casp12 is localized at the ER and is activated by ER stress, e.g., by an insufficient UPR ([@bib31]). It was previously shown that managing the UPR is essential for PC survival ([@bib21]; [@bib36]) because they are cells producing several thousand antibody molecules per second ([@bib19]). Which ER stress pathway is relevant for PCs is still not clear. The genetic ablation of the three main ER stress pathways XBP-1 ([@bib45]), ATF6 ([@bib2]), and PERK ([@bib25]) individually did not result in an ablation of antibody-secreting cells, indicating that there might be redundancy in the ER stress pathways in PCs, which are apparently all addressed by BCMA signaling.

The original notion that direct cell contact between stromal cells and PCs is essential for the survival of PCs in the BM comes from their ablation *in vivo* by antibodies against integrin α4β1 (VLA-4), a ligand of the stromal cell receptor VCAM1, and integrin αLβ2 (LFA-1), a ligand of the stromal cell receptor ICAM-1, which are both expressed by BM PCs ([@bib11]). At a molecular level, it has been demonstrated that integrins can signal by the FAK/PI3K pathway ([@bib13]). An indication that this may also happen in PCs comes from mice deficient for the tetraspanin CD37. In these mice, antibody-secreting cells showed impaired clustering of VLA4 and diminished PI3K signaling *ex vivo* ([@bib49]). Here, we demonstrate by transwell separation of PCs and stromal cells in the *ex vivo* niche that direct contact of BM PCs to ST2 cells is required for the survival of the PCs. The contact induces PI3K signaling in the PCs, which is required for their survival. Inhibitors specific for the α, β, γ, or δ subunits of PI3K in any combination of three blocked PC survival, suggesting that PCs can use any two of the four different PI3K subunits for survival signaling in a redundant fashion. Also, the PI3K inhibitors LY29400 and Wortmannin efficiently block *ex vivo* survival of the PCs. Wortmannin also ablates PCs from BM *in vivo*. Considering the different spectra of off-target effects of all those inhibitors, the results strongly suggest that indeed stromal-cell-contact-induced PI3K signaling is vital for memory PC survival. The cell contact in part is mediated by β1-integrin because siRNA-mediated knockdown of β1 integrin in PCs impairs the survival of these cells in the *ex vivo* niche, as we show here.

PI3K signaling by activation of AKT has several downstream targets. One of them is the mechanistic target of rapamycin complex 1 (mTORC1). This has previously been shown not to be involved in memory PC survival ([@bib22]). Others are the transcription factors FoxO1/3. Activated AKT phosphorylates FoxO1/3, thus inactivating them as transcription factors. Inactivation of FoxO1/3 has been shown to be essential for survival and proliferation of activated lymphocytes, although the exact molecular mechanisms remain enigmatic ([@bib15]; [@bib44]). Here, we show that inactivation of FoxO1/3 is essential for the survival of memory PCs because siRNA-mediated knockdown of FoxO1/3 in the PCs nearly fully compensates for stromal cell contact in the *ex vivo* niche.

Unlike APRIL, stromal cells block activation of the Casp3 and 7, but not 12, in BM PCs in the *ex vivo* niche. Casp3 and 7 have been reported to be activated upon mitochondrial stress ([@bib24]). Inhibition of Casp3 and 7 by stromal cell contact and of Casp12 by APRIL seem to be necessary and sufficient to prevent apoptosis of memory PCs in the *ex vivo* niche. Pan-caspase inhibition can compensate for either one, ST2 cells or APRIL. Although stromal cell contact blocks the effector caspases of mitochondrial-stress-induced apoptosis, APRIL blocks the initiator caspase of ER-stress-induced apoptosis Casp12, which are apparently the two major stress factors limiting the lifetime of memory PCs. Also, the expression of the essential survival factor IRF4 ([@bib46]) is upregulated by stromal cell contact and APRIL in synergy, as we show here. Taken together, our results demonstrate that stromal cells are not simply organizing memory PC survival niches in the BM. By integrin-mediated cell contact, they actively provide an essential survival signal to memory PCs, complementing the survival signal provided by APRIL/BAFF. Both signals efficiently prevent mitochondrial- and ER-stress-induced apoptosis of memory PCs.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Anti-mouse active caspase 3Cell Signaling TechnologyCatalog \# 8788; RRID:[AB_2797665](nif-antibody:AB_2797665){#interref50}Anti-mouse active caspase 7Cell Signaling TechnologyCatalog \# 8438T; RRID:[AB_11178377](nif-antibody:AB_11178377){#interref55}Anti-mouse BCL2, APC, REA356Miltenyi BiotecCatalog \# 130-105-474; RRID:[AB_2651266](nif-antibody:AB_2651266){#interref60}Anti-mouse BIM, 14A8MiliporeCatalog \# MAB17001; RRID:[AB_2065314](nif-antibody:AB_2065314){#interref65}Anti-mouse CD138, PE-vio770, REA104Miltenyi BiotecCatalog \# 130-102-318; RRID:[AB_2655025](nif-antibody:AB_2655025){#interref70}Anti-mouse FoxO1, C29H4Cell Signaling TechnologyCatalog \# 2880; RRID:[AB_2106495](nif-antibody:AB_2106495){#interref75}Anti-mouse FoxO3a, D19A7Cell Signaling TechnologyCatalog \# 12829; RRID:[AB_2636990](nif-antibody:AB_2636990){#interref80}Anti-mouse IRF4, APC, REA201Miltenyi BiotecCatalog \# 130-100-913; RRID:[AB_2652517](nif-antibody:AB_2652517){#interref85}Anti-mouse MCL1, Y37AbcamCatalog \# ab32087; RRID:[AB_776245](nif-antibody:AB_776245){#interref90}Anti-mouse NOXA, 114C307AbcamCatalog \# ab13654; RRID:[AB_300536](nif-antibody:AB_300536){#interref95}Anti-mouse ki67,A488, B56BDCatalog \# 558616; RRID:[AB_647087](nif-antibody:AB_647087){#interref100}Anti-mouse B220, PE, REA755Miltenyi BiotecCatalog \# 130-110-709; RRID:[AB_2658276](nif-antibody:AB_2658276){#interref105}Anti-mouse B220, Bio, RA3-6B2Miltenyi BiotecCatalog \# 130-101-928; RRID:[AB_2660454](nif-antibody:AB_2660454){#interref110}Anti-mouse CD19, APC, REA749Miltenyi BiotecCatalog \# 130-112-036; RRID:[AB_2655824](nif-antibody:AB_2655824){#interref115}Anti-mouse CD49d, bio, R1-2Miltenyi BiotecCatalog \# 130-101-912; RRID:[AB_2660744](nif-antibody:AB_2660744){#interref120}Anti-mouse IgA, polyclonalSouthern BiotechCatalog \# 1040-08; RRID:[AB_2794374](nif-antibody:AB_2794374){#interref125}Anti-mouse IgG, polyclonalSouthern BiotechCatalog \# 1036-01; RRID:[AB_2794345](nif-antibody:AB_2794345){#interref130}Anti-mouse IgM, polyclonalSouthern BiotechCatalog \# 1021-01; RRID:[AB_2687524](nif-antibody:AB_2687524){#interref135}Anti-mouse CD19, PacB, 1D3DRFZN/A**Chemicals, Peptides, and Recombinant Proteins**4-hydroxy-3-nitropheylacetyl hapten coupled chicken gamma globulinBiomolCatalog \# D602-0100Incomplete Freud\`s AdjuvansSIGMACatalog \# F5506WortmanninSelleckchemCatalog \# S2758Ly294002SelleckchemCatalog \# S1105IKK16SelleckchemCatalog \# S2882Z-VAD-FMKSanta Cruz BiotechnologyCatalog\# CAS 187389-52-2Formaldehyde solutionElectron microscopyCatalog \# 15713SRecombinant APRIL mouse multimericAdipo gen Life SciencesCatalog \# AG-40B-0089-3010Anti-mouse CD138 microbeadsMiltenyi BiotechCatalog \# 130-098-257Anti-Streptavidin microbeadsMiltenyi BiotechCatalog \# 130-048-101**Oligonucleotides**FoxO1SMARTPoolCatalog \# E-041127-00-0010FoxO3SMARTPoolCatalog \# E-040728-00-0010ITGB1Individual siRNACatalog \# A-040783-13-0020Non-TargetingIndividual siRNACatalog \# D-001910-04-20**Critical Commercial Assays**RNeasy Micro KITQuiagenCatalog \# 74004Whole-transcriptome pico KITThermoFisher ScientificCatalog \# 902622Cell Signaling Buffer Set AMiltenyi BiotecCatalog \# 130-100-827CaspGLOW Fluorescein Active Caspase-12 Staining KitBiovision GmbHCatalog \# K172-100**Deposited Data**Transcriptome dataThis paperGEO: [GSE107206](ncbi-geo:GSE107206){#intref0010}**Experimental Models: Cell Lines**ST2 stromal cell lineRiken BioResource CenterCatalog \# RCB0224**Experimental Models: Organisms/Strains**Mouse: C57BL/6JCharles River LaboratoriesCatalog \# 000664Mouse: C57BL/6J Blimp-1:GFPS. Nutt (Walter and Eliza Hall Institute, Melbourne, Australia)N/A**Software and Algorithms**FlowJo10FlowJo LLC<http://www.flowjo.com>PrismGraphPad Software, Inc<http://www.graphpad.com>**Other**MG_U430_2 GeneChipsThermoFisher ScientificCatalog \# 900495

Resource Availability {#sec4.2}
---------------------

### Lead Contact {#sec4.2.1}

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Andreas Radbruch (<radbruch@drfz.de>).

### Materials Availability {#sec4.2.2}

This study did not generate new unique reagents.

### Data and Code Availability {#sec4.2.3}

The datasets generated during this study are available at GEO: [GSE107206](ncbi-geo:GSE107206){#intref0030}.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Mice {#sec4.3.1}

C57BL/6J wild-type strain was purchased from Charles River Laboratories. Mice expressing GFP under the control of the Prdm1 promoter (Blimp-1:GFP) were bred and maintained at the "Bundesinstitut für Risikobewertung" (BfR, Berlin, Germany), a gift from S. Nutt (Walter and Eliza Hall Institute, Melbourne, Australia). All mice were maintained under specific pathogen free conditions. All experiments were performed according to German law for animal protection and with the permission from the local veterinary offices, and in compliance with the guidelines of the Institutional Animal Care and Use Committee. The animal experiments were performed within the animal studies H007015 and G008-13.

### Health/immune status {#sec4.3.2}

All animals are fully immune competent and are obtained from controlled SPF-breeding facilities. They are subsequently housed in IVC cages under SPF conditions. Animal health is constantly monitored in accordance with FELASA recommendations.

### Husbandry/housing conditions of experimental animals {#sec4.3.3}

All animals are housed in IVC cages with a maximum of 5 animals per cage. The animals are provided with enrichment in form of nesting material and wood. Special, autoclaved food as well as autoclaved water is supplied *ad libitum*. Cages are equipped with wood chip bedding material and a shelter made from red plastics. Animals have a settling-in-period of five days after arrival from breeding facilities. Animals are exposed to light for a cycle of 12 hours, followed by 12 hours of darkness.

### ST2 cell line {#sec4.3.4}

ST2 cells are originally isolated from the bone marrow of a BALB/c mouse. Their morphology is fibroblast-like. Cells were cultured in RPMI1640 + 10% FCS, 100 U/ml Penicillin, 100 μg/ml streptomycin, 0.1% β-Mercaptoethanol. Cells were passaged twice a week using trypsin, the passage ratio was 1:10.

Method Details {#sec4.4}
--------------

### Immunization {#sec4.4.1}

Mice were primed with 100μg 4-hydroxy-3-nitropheylacetyl hapten coupled chicken gamma globulin (NP-CGG) in incomplete Freud\`s Adjuvants (IFA) intraperitoneally (i.p.). In total 200μl (100μl of NP-CGG diluted in PBS + 100μl IFA) have been injected per mouse. Mice were challenged twice after the prime with the same injection in cycles of 21 days.

### *In vivo* treatment with PI3K-inhibitor {#sec4.4.2}

Immunized mice were used and Wortmannin in DMSO or PBS in DMSO injected i.p. with a total volume of 100μl on day 90, 92 and 94. Concentration of Wortmannin was 1.2mg/kg. Mice were killed by cervical dislocation and analyzed on day 95.

### Magnetic isolation of long-lived PCs from the bone marrow {#sec4.4.3}

PCs were magnetically isolated from immunized mice more than 30 days after 2^nd^ boost using a two-step protocol, including depletion of B220 and CD49b expressing cells and subsequent positive enrichment of CD138^high^ PCs.

### Cell culture of long-lived PCs and treatment with inhibitors {#sec4.4.4}

Isolated long-lived PCs from the bone marrow were cultured in RPMI1640 medium supplemented with 10% FCS, 100 U/ml Penicillin, 100 μg/ml streptomycin, 0.1% β-Mercaptoethanol, 25 mM HEPES buffer and 50 ng/ml multimeric APRIL. Cultures were kept under physiological oxygen levels in a hypoxia chamber with 4.2% O~2~ and 5% CO~2~ at 37°C. For the co-culture, 2500 ST2 cells were seeded in a 96-well plate one day before memory PC isolation. Memory PCs were plated on top the ST2 cell layer in a 1:1 ratio (5000 PC and 5000 ST2 cells). For analysis, cells were either fixed with PFA or stained directly and scraped off the plate before measurement. Cells were pre-treated with pan PI3K inhibitors at different concentrations including Wortmannin, Ly294002 and to block NF-κB pathway the inhibitor, IKK16, was used.

### siRNA treatment of PCs *in vitro* {#sec4.4.5}

Isolated long-lived PCs from the bone marrow were cultured in Accell Medium with 2 μM siRNA or scr control ([@bib3]; [@bib16]) and 100 ng/ml multimeric APRIL. After 1 hour RMI1640 medium supplemented with 5% FCS, 200 U/ml Penicillin, 200 μg/ml streptomycin0.2% β-Mercaptoethanol, 50 mM HEPES buffer was added to the cells. Cultures were kept under physiological oxygen levels in a hypoxia chamber with 4.2% O~2~ and 5% CO~2~ at 37°C.

### Caspase stainings {#sec4.4.6}

For activated caspase 12, Caspase 12 CaspGlow assay was performed by staining the cells in cell culture medium with the CaspGlow FITC labeled peptide for 30 minutes at 37°C. Cells were washed two times, stained for CD138 and measured by flow cytometry. For caspases 3 and 7, specific antibodies were used. Cells were fixed with 4% PFA for 10 minutes and permeabilized with methanol. To block unspecific binding, cells were incubated with uncoupled anti-FCyRII/III antibody prior to staining with primary antibody for 1 hour. After washing, cells were incubated with a secondary antibody for 30 minutes. All samples were analyzed using a MacsQuant analyzer and FlowJo software. As negative control, cells were incubated for 24 hours with 10 μM panCaspase Inhibitor Z-VAD-FMK. As positive controls, cells were incubated with 10 μM Wortmannin or 2.5 μM Tunicamycin for 2 hours prior to staining.

### Flow cytometric measurement of surface and intracellular antigens {#sec4.4.7}

Single cell suspension was prepared; cells were pre-incubated with uncoupled anti-FCyRII/III antibody to block unspecific binding, followed by direct addition of antibodies for 15 minutes on ice. For staining of intracellular antigens, cells were fixed with PFA and permeabilized with methanol. To prevent unspecific binding, cells were pre-incubated with blocking buffer containing rabbit or rat serum and subsequently stained with primary antibody for 1 hour and, if necessary, with secondary antibody for 30 minutes. Samples were analyzed using a MacsQuant analyzer and FlowJo software. Cytometric procedures followed the recommendations of the "Guidelines for use of flow cytometry and cell sorting in immunological studies" ([@bib10]).

### ELISA {#sec4.4.8}

Enzyme-linked immunosorbent assay was used to detect secreted antibodies in supernatants at different time points of the PC culture. The supernatant was collected over 6 days. Plates were coated with unlabeled IgG, IgM or IgA in PBS overnight, followed by a washing step with PBS. Plates were blocked with 3% BSA/PBS. Supernatants either undiluted or diluted 1:12, 1:32 or 1:108 were incubated at 37°C for 2 hours in plates coated with unlabeled IgG, IgM or IgA. Plates were washed with PBS/Tween 0.05% followed by addition of anti-IgG, anti-IgM and anti-IgA conjugated to Biotin (diluted 1:2000) and incubation at 4°C overnight. Plates were washed with PBS/BSA and incubated with Streptavidin-Peroxidase at 37°C for 20 minutes. Plates were washed with tap water. TMB was added followed by stop solution (2M H~2~SO~4~). For the read out a spectrophotometer was used (wavelenght 450 nm).

### Transwell-Assay {#sec4.4.9}

Isolated PCs were cultured in transwell plates with pore size of 0.5μm. PCs were plated at the bottom of the transwell plate in the presence of APRIL in a total volume of 600 μL. 2500 stromal cells were plated the day before in the transwell insert. As control of direct contact effects PCs were plated directly onto stromal cells in the transwell insert. On the day of analysis, plasma cells were collected by scraping and directly measured using CD138 and DAPI staining.

### Processing and analysis of oligonucleotide microarray data {#sec4.4.10}

Memory PCs were isolated by magnetic cell sorting or after 3 days of culture in the *in vitro* system were processed for RNA preparation. RNA was prepared using the RNeasy Micro KIT and hybridized to mouse 430 2 GeneChips according to the whole-transcriptome pico KIT. Raw signals were processed by the affy R package using RMA for normalization ([@bib12]). Sample similarity was evaluated by Pearson correlation and Principle component analysis based on un-scaled log2 expression values. For the differentially expressed gene analysis the limma R package was used ([@bib40]). Genes with an adjusted P value \< 0.05 were considered to be statistically differentially expressed. Microarray data is available through Gene Expression Omnibus (GEO:[GSE107206](ncbi-geo:GSE107206){#intref0035}; code for reviewer: sfctqoakblqhpyp).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Data are presented as median. Data was tested for normality and significant differences between two or more groups were determined by performing Mann-Whitney test, Kruskal-Wallis test or ordinary one-way ANOVA. Differences were considered statistically significant when p \< 0.05. Detailed information can be found in the respective figure legend. Technical replicates refer to the number of wells in a 96 well plate of one experiment. Biological replicates refer to independent experiments performed on different days.
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========================

Document S1. Figures S1--S4Document S2. Article plus Supplemental Information

We thank Tuula Geske, Heidi Hecker-Kia, and Heidi Schliemann for their expert technical help; Toralf Kaiser and Jenny Kirsch as operators of the flow cytometry core facility (FCCF); and Patrick Thiemann and Manuela Ohde for assistance with animal care. This work was supported by 10.13039/501100000781European Research Council Advanced Grant IMMEMO (ERC-2010-AdG.20100317 Grant 268987; to A.R.), by the 10.13039/501100001659Deutsche Forschungsgemeinschaft (TRR130 to A.R. and H.-D.C.), and Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 777357. G.P. and F.M. were supported by the state of Berlin and the "European Regional Development Fund" (ERDF 2014--2020, EFRE 1.8/11, Deutsches Rheuma-Forschungszentrum Berlin). F.S. was supported by Osteoimmune, a FP7 Marie Curie Initial Training Network (FP7-PEOPLE-2011-ITN-289150). E.M. was supported by the 10.13039/501100001659Deutsche Forschungsgemeinschaft (MO 2934/1-1-1). This work was supported by the Leibniz ScienceCampus Chronic Inflammation (<http://www.drfz.de/forschung/chronischen-entzuendungen>).

Author Contributions {#sec5}
====================

R.C. and S.H. designed and performed the experiments, analyzed and interpreted the data, and wrote the manuscript. D.M., M.T., C.K., L.H., and F.S. carried out and analyzed certain experiments. B.F.H. and F.H. provided mouse strains and helped to write the manuscript. G.P., A.T., P.D., E.M., K.T., F.M., and M.-F.M. analyzed data and provided scientific suggestions. H.-D.C. and A.R. conceived the study and wrote the manuscript.

Declaration of Interest {#sec6}
=======================

The authors declare no competing interests.

Supplemental Information can be found online at <https://doi.org/10.1016/j.celrep.2020.107982>.

[^1]: These authors contributed equally

[^2]: These authors contributed equally

[^3]: Present address: Institute of Life Technologies, University of Applied Sciences and Arts Western Switzerland, Delémont, Switzerland

[^4]: Present address: Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

[^5]: Lead Contact
